tromethamine has been researched along with nimodipine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arjona-Padillo, A; De la Torre-Colmenero, JD; Fernandez-Perez, J | 1 |
1 review(s) available for tromethamine and nimodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for tromethamine and nimodipine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion].
Topics: Apraxias; Bupropion; Calcium Channel Blockers; Carotid Stenosis; Cerebral Arteries; Cerebrovascular Disorders; Drug Substitution; Female; Gait Disorders, Neurologic; Headache Disorders, Primary; Humans; Ketoprofen; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Nimodipine; Personality Disorders; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tension-Type Headache; Tromethamine; Vasoconstriction | 2018 |